Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

348 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cardiac glycosides as novel cancer therapeutic agents.
Newman RA, Yang P, Pawlus AD, Block KI. Newman RA, et al. Mol Interv. 2008 Feb;8(1):36-49. doi: 10.1124/mi.8.1.8. Mol Interv. 2008. PMID: 18332483 Review.
Phase II study of 4-demethoxydaunorubicin in previously untreated extensive disease non-small cell lung cancer.
Umsawasdi T, Felder TB, Jeffries D, Newman RA. Umsawasdi T, et al. Among authors: newman ra. Invest New Drugs. 1990;8 Suppl 1:S73-8. doi: 10.1007/BF00171988. Invest New Drugs. 1990. PMID: 2166007
Significance of C1q-binding macromolecules within the head and neck cancer patient.
Schantz SP, Savage HE, Brown BW, Young G, Liu FJ, Reger G, Newman RA. Schantz SP, et al. Among authors: newman ra. Cancer Res. 1990 Jul 15;50(14):4349-54. Cancer Res. 1990. PMID: 2364389
In vitro activity of bleomycin, tallysomycin S10b, and liblomycin against fresh human tumor cells.
Tueni EA, Newman RA, Baker FL, Ajani JA, Fan D, Spitzer G. Tueni EA, et al. Among authors: newman ra. Cancer Res. 1989 Mar 1;49(5):1099-102. Cancer Res. 1989. PMID: 2465080
Metabolism of new anticancer agents.
Siddik ZH, Newman RA. Siddik ZH, et al. Among authors: newman ra. Pharmacol Ther. 1989;41(1-2):163-94. doi: 10.1016/0163-7258(89)90105-8. Pharmacol Ther. 1989. PMID: 2652150 Review. No abstract available.
Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.
Hoffman K, Holmes FA, Fraschini G, Esparza L, Frye D, Raber MN, Newman RA, Hortobagyi GN. Hoffman K, et al. Among authors: newman ra. Cancer Chemother Pharmacol. 1996;37(3):254-8. doi: 10.1007/BF00688325. Cancer Chemother Pharmacol. 1996. PMID: 8529286 Clinical Trial.
Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A2 toxin. A novel growth inhibitory mechanism.
Donato NJ, Martin CA, Perez M, Newman RA, Vidal JC, Etcheverry M. Donato NJ, et al. Among authors: newman ra. Biochem Pharmacol. 1996 Jun 14;51(11):1535-43. doi: 10.1016/0006-2952(96)00097-4. Biochem Pharmacol. 1996. PMID: 8630095
Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer.
Tu SM, Pagliaro LC, Banks ME, Amato RJ, Millikan RE, Bugazia NA, Madden T, Newman RA, Logothetis CJ. Tu SM, et al. Among authors: newman ra. Clin Cancer Res. 1998 May;4(5):1193-201. Clin Cancer Res. 1998. PMID: 9607577 Clinical Trial.
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
Li C, Yu DF, Newman RA, Cabral F, Stephens LC, Hunter N, Milas L, Wallace S. Li C, et al. Among authors: newman ra. Cancer Res. 1998 Jun 1;58(11):2404-9. Cancer Res. 1998. PMID: 9622081
Novel marine-derived anticancer agents: a phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors.
Madden T, Tran HT, Beck D, Huie R, Newman RA, Pusztai L, Wright JJ, Abbruzzese JL. Madden T, et al. Among authors: newman ra. Clin Cancer Res. 2000 Apr;6(4):1293-301. Clin Cancer Res. 2000. PMID: 10778954 Clinical Trial.
348 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page